Taro Yamashita

发表

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.

Xin Wei Wang, X. Wang, M. Forgues, 2007, Cancer research.

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Izumi Horikawa, Jun Yokota, Seiichi Takenoshita, 2008, Cancer research.

cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation.

Masao Honda, Shuichi Kaneko, M. Honda, 2005, Journal of autoimmunity.

Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma

Hyun Goo Woo, Stephanie Roessler, Xin Wei Wang, 2012, Hepatology.

Comparative analysis of various tumor‐associated antigen‐specific t‐cell responses in patients with hepatocellular carcinoma

Masao Honda, Shuichi Kaneko, Yoshio Sakai, 2011, Hepatology.

Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C

Motoko Sasaki, Masao Honda, Shuichi Kaneko, 2013, Clinical Cancer Research.

Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.

Motoko Sasaki, Katsuhisa Horimoto, Masao Honda, 2008, Journal of hepatology.

Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.

Katsuhisa Horimoto, Sachiyo Aburatani, Masao Honda, 2013, Genomics.

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Jin Woo Kim, Wei Wang, Xin Wei Wang, 2008, Cancer research.